Erich Maximilian Platzer
Chairman chez VIVORYON THERAPEUTICS N.V.
Fortune : 55 886 $ au 31/03/2024
Profil
Dr. Erich Maximilian Platzer is a Healthcare Partner at MTIP AG, an Independent Director at Aptose Biosciences, Inc., a Non-Executive Chairman at Vivoryon Therapeutics NV, a Chairman at Advanced Osteotomy Tools - AOT AG, a Chairman-Supervisory Board at TeGenero AG and a Managing Director at Platzer Consult GmbH.
He is on the Board of Directors at Panavance Therapeutics, Inc., Peripal AG, Aptose Biosciences, Inc., AOT AG, Bio-Bac, Inc., StartAngels Network and Platzerinvest AG.
Dr. Platzer was previously employed as a Chairman by Leman Micro Devices SA, a Chairman by credentis ag, a Co-Founder by HBM Healthcare Investments AG, an Investment Advisor by HBM Partners AG, a Business Director-Oncology Worldwide by F.
Hoffmann-La Roche Ltd., a Member by Memorial Sloan Kettering Cancer Center, a Chairman-Supervisory Board by Ingenium Pharmaceuticals GmbH, a Chairman by Micromet AG, a Member-Supervisory Board by mtm laboratories AG, and a Chairman by Novuspharma SpA.
He also served on the board at BC Platforms AG, Viroblock SA, Nereus Pharmaceuticals, Inc., Cell Therapeutics, Inc., Cylene Pharmaceuticals, Inc., Locus Pharmaceuticals, Inc. and Reha-Stim Medtec AG.
He received his undergraduate degree from Friedrich-Alexander University of Erlangen-Nuremberg, an undergraduate degree from the University of Regensburg and a doctorate degree from Friedrich-Alexander University of Erlangen-Nuremberg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
APTOSE BIOSCIENCES INC.
0,21% | 05/02/2024 | 33 666 ( 0,21% ) | 55 886 $ | 31/03/2024 |
Postes actifs de Erich Maximilian Platzer
| Sociétés | Poste | Début |
|---|---|---|
| APTOSE BIOSCIENCES INC. | Director/Board Member | 15/12/2014 |
| VIVORYON THERAPEUTICS N.V. | Chairman | 01/01/2007 |
StartAngels Network
 StartAngels Network Packaged SoftwareTechnology Services StartAngels Network operates as a platform for business angel investors. Its angle investors invest directly in the start-up companies, coach them, and provide useful contacts. The company was founded by Peter H. Müller in 2000 and is headquartered in Zurich, Switzerland. | Director/Board Member | 01/01/2012 |
AOT AG
 AOT AG Medical SpecialtiesHealth Technology AOT AG develops and manufactures robotic surgery equipment. Its technologies include laser photoablation, navigation, planning, and image tools, and real time controlling systems. The company was founded in 2011 and is headquartered in Basel, Switzerland. | Director/Board Member | 01/12/2022 |
MTIP AG
 MTIP AG Investment ManagersFinance MTIP AG (MTIP) is an independent private equity/venture capital firm founded in 2014. The firm is headquartered in Basel, Switzerland. | Private Equity Investor | 01/01/2015 |
Peripal AG
 Peripal AG Medical SpecialtiesHealth Technology Peripal AG engages in the development and commercialization of aid for the dialysis. It offers PeriSafe a novel patient assist device for the safe and easy connection in Peritoneal Dialysis. The company was founded by Sandra Neumann in 2015 and is headquartered in Zurich, Switzerland. | Director/Board Member | 01/01/2016 |
Bio-Bac, Inc.
 Bio-Bac, Inc. Chemicals: SpecialtyProcess Industries Bio-Bac, Inc. specializes in biological treatment of organic waste through a bacterial bioaugmentation process. Its solutions include wastewater treatment, nitrification – ammonia degradation, ponds and water gardens, golf, hydrocarbons, household and commercial and agricultural treatment. The company is headquartered in Sherbrooke, Canada. | Director/Board Member | 01/01/2012 |
Advanced Osteotomy Tools - AOT AG
 Advanced Osteotomy Tools - AOT AG Medical SpecialtiesHealth Technology Advanced Osteotomy Tools-AOT AG develops, manufactures, and markets medical devices and tools for bone-cutting. Its device combines three-dimensional (3D) pre-operative planning and a navigation system with a miniaturized laser mounted on a robotic arm. The company was founded by Alfredo E. Bruno, Philippe Cattin, Philipp Jürgens, and Hans-Florian Zeilhofer in 2011 and is headquartered in Allschwil, Switzerland. | Chairman | - |
| Platzer Consult GmbH | Chief Executive Officer | - |
| ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Erich Maximilian Platzer
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Erich Maximilian Platzer
| Friedrich-Alexander University of Erlangen-Nuremberg | Doctorate Degree |
| University of Regensburg | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| Entreprise privées | 27 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Finance |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Viroblock SA
 Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Commercial Services |
| Novuspharma SpA | Health Technology |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Health Technology |
Ingenium Pharmaceuticals GmbH
 Ingenium Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Ingenium Pharmaceuticals GmbH operates as a biopharmaceutical company specializing in the development of small molecule drugs. They develop inhibitors and ligands targeting key enzymes such as proteases and kinases. Their therapeutic compounds are used for the treatment of memory-related and chronic inflammatory disorders. Their focus areas cover human therapeutics, vivo pharmacology, and disease pathology. The company was founded in 1998 and is headquartered in Munich, Germany. | Commercial Services |
Locus Pharmaceuticals, Inc.
 Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
HBM Healthcare Investments AG
 HBM Healthcare Investments AG Investment ManagersFinance HBM Healthcare Investments AG is a listed investment company which invests worldwide, primarily focusing on Europe, Asia and North America, in private and public companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. It aims to invest mainly in a form of equity, but also considers convertible bonds, debt securities and derivatives. The investment focus is on later stage companies, and participates in follow-on investment rounds, also acquiring majority stake in target companies. It invests also in other funds. | Finance |
Nereus Pharmaceuticals, Inc.
 Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Commercial Services |
mtm laboratories AG
 mtm laboratories AG Medical SpecialtiesHealth Technology mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec® Histology kit and CINtec® Cytology kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4™ antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results. mtm laboratories AG also has programs to identify and develop biomarker based diagnostics for other cancer indications. With its extensive and ever increasing network of clinical research institutions, academic research organizations, and medical professionals active in the field of oncology and molecular pathology, mtm has established a rapid, integrated process for the successful identification and clinical validation of molecular markers associated with cancer. | Health Technology |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Health Services |
TeGenero AG
 TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | Health Technology |
credentis ag
 credentis ag Medical SpecialtiesHealth Technology credentis ag designs, develops, manufactures, and markets dental devices. The firm offers CURODONT. The company was founded by Dominik A. Lysek in January 2010 and is headquartered in Windisch, Switzerland. | Health Technology |
StartAngels Network
StartAngels Network Packaged SoftwareTechnology Services StartAngels Network operates as a platform for business angel investors. Its angle investors invest directly in the start-up companies, coach them, and provide useful contacts. The company was founded by Peter H. Müller in 2000 and is headquartered in Zurich, Switzerland. | Technology Services |
Reha-Stim Medtec AG
 Reha-Stim Medtec AG Medical SpecialtiesHealth Technology YouRehab AG creates interactive therapy systems for neurological motor disorders. It offers YouGrabber, an all-in-one upper limb rehabilitation product for arms and fingers, which trains patients at peak intensity using rehabilitation gaming to enahcne clinical outcomes; YouKicker, a lower limb rehabilitation product for legs and feet. The company was founded by Oliver Ullmann, Kynan Eng, Edith Chevrier, Lisa Holper, Daniel Kiper, Pawal Pyk and Ewa Siekierka in April 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
Advanced Osteotomy Tools - AOT AG
Advanced Osteotomy Tools - AOT AG Medical SpecialtiesHealth Technology Advanced Osteotomy Tools-AOT AG develops, manufactures, and markets medical devices and tools for bone-cutting. Its device combines three-dimensional (3D) pre-operative planning and a navigation system with a miniaturized laser mounted on a robotic arm. The company was founded by Alfredo E. Bruno, Philippe Cattin, Philipp Jürgens, and Hans-Florian Zeilhofer in 2011 and is headquartered in Allschwil, Switzerland. | Health Technology |
| Platzerinvest AG | |
| Platzer Consult GmbH | |
Leman Micro Devices SA
 Leman Micro Devices SA SemiconductorsElectronic Technology Leman Micro Devices SA engages in the development of sensor and software systems that measures blood pressure, body temperature, blood oxygen saturation, heart rate and respiration rate in smartphone. The company was founded by Chris Elliott and Mark-Eric Jones in 2010 and is headquartered in Lausanne, Switzerland. | Electronic Technology |
Bio-Bac, Inc.
Bio-Bac, Inc. Chemicals: SpecialtyProcess Industries Bio-Bac, Inc. specializes in biological treatment of organic waste through a bacterial bioaugmentation process. Its solutions include wastewater treatment, nitrification – ammonia degradation, ponds and water gardens, golf, hydrocarbons, household and commercial and agricultural treatment. The company is headquartered in Sherbrooke, Canada. | Process Industries |
Peripal AG
Peripal AG Medical SpecialtiesHealth Technology Peripal AG engages in the development and commercialization of aid for the dialysis. It offers PeriSafe a novel patient assist device for the safe and easy connection in Peritoneal Dialysis. The company was founded by Sandra Neumann in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
MTIP AG
MTIP AG Investment ManagersFinance MTIP AG (MTIP) is an independent private equity/venture capital firm founded in 2014. The firm is headquartered in Basel, Switzerland. | Finance |
BC Platforms AG
 BC Platforms AG Data Processing ServicesTechnology Services BC Platforms AG provides powerful genomic data management and analysis solutions. It offers pharmaceutical, biobank, healthcare and academia products. The company was founded by Timo Kanninen in 1997 and is headquartered in Basel, Switzerland. | Technology Services |
| Panavance Therapeutics, Inc. | |
AOT AG
AOT AG Medical SpecialtiesHealth Technology AOT AG develops and manufactures robotic surgery equipment. Its technologies include laser photoablation, navigation, planning, and image tools, and real time controlling systems. The company was founded in 2011 and is headquartered in Basel, Switzerland. | Health Technology |
